Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • Authors & Reviewers
    • Overview for Authors
    • Preparing manuscripts
    • Submission Checklist
    • Publication Fees
    • Forms
    • Editorial Policies
    • Editorial Process
    • Patient-Oriented Research
    • Submit a manuscript
    • Manuscript Progress
    • Submit a response
    • Information for Reviewers
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ Open
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN
CMAJ Open

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • Authors & Reviewers
    • Overview for Authors
    • Preparing manuscripts
    • Submission Checklist
    • Publication Fees
    • Forms
    • Editorial Policies
    • Editorial Process
    • Patient-Oriented Research
    • Submit a manuscript
    • Manuscript Progress
    • Submit a response
    • Information for Reviewers
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow CMAJ Open on Twitter
Research
Open Access

Introduction of publicly funded pharmacare and socioeconomic disparities in glycemic management in children and youth with type 1 diabetes in Ontario, Canada: a population-based trend analysis

Mohana Giruparajah, Karl Everett, Baiju R. Shah, Peter C. Austin, Shai Fuchs and Rayzel Shulman
June 14, 2022 10 (2) E519-E526; DOI: https://doi.org/10.9778/cmajo.20210214
Mohana Giruparajah
Division of Endocrinology (Giruparajah, Fuchs, Shulman), The Hospital for Sick Children; ICES (Everett, Shah, Austin, Shulman); Institute for Health Policy, Management and Evaluation (Austin), University of Toronto; Department of Medicine (Shah), Sunnybrook Health Sciences Centre, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl Everett
Division of Endocrinology (Giruparajah, Fuchs, Shulman), The Hospital for Sick Children; ICES (Everett, Shah, Austin, Shulman); Institute for Health Policy, Management and Evaluation (Austin), University of Toronto; Department of Medicine (Shah), Sunnybrook Health Sciences Centre, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baiju R. Shah
Division of Endocrinology (Giruparajah, Fuchs, Shulman), The Hospital for Sick Children; ICES (Everett, Shah, Austin, Shulman); Institute for Health Policy, Management and Evaluation (Austin), University of Toronto; Department of Medicine (Shah), Sunnybrook Health Sciences Centre, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter C. Austin
Division of Endocrinology (Giruparajah, Fuchs, Shulman), The Hospital for Sick Children; ICES (Everett, Shah, Austin, Shulman); Institute for Health Policy, Management and Evaluation (Austin), University of Toronto; Department of Medicine (Shah), Sunnybrook Health Sciences Centre, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shai Fuchs
Division of Endocrinology (Giruparajah, Fuchs, Shulman), The Hospital for Sick Children; ICES (Everett, Shah, Austin, Shulman); Institute for Health Policy, Management and Evaluation (Austin), University of Toronto; Department of Medicine (Shah), Sunnybrook Health Sciences Centre, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rayzel Shulman
Division of Endocrinology (Giruparajah, Fuchs, Shulman), The Hospital for Sick Children; ICES (Everett, Shah, Austin, Shulman); Institute for Health Policy, Management and Evaluation (Austin), University of Toronto; Department of Medicine (Shah), Sunnybrook Health Sciences Centre, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Figure 1:
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1:

    Predicted hemoglobin A1c (HbA1c, %) over time before and during the Ontario Health Insurance Plan (OHIP)+ program (n = 6347). Linear predictions of HbA1c before OHIP+ (Jan. 1, 2016, to Dec. 31, 2017) and during OHIP+ (Apr. 1, 2018, to Mar. 31, 2019) by deprivation quintile (Q1 = least deprived, Q5 = most deprived).

Tables

  • Figures
    • View popup
    Table 1:

    Baseline characteristics of youth (aged 21 years, 9 months or younger) who had and did not have an insulin claim during coverage by the Ontario Health Insurance Plan (OHIP)+ program (Jan. 1, 2018, to Mar. 31, 2019)

    CharacteristicNo. (%) of youth*
    Entire cohort
    n = 9641
    At least 1 insulin claim during OHIP+
    n = 7041
    No insulin claim during OHIP+
    n = 2600
    Any drug claim during OHIP+8704 (90.3)7041 (100.0)1663 (64.0)
    Metformin claim during OHIP+341 (3.5)225 (3.2)116 (4.5)
    Age, yr; mean ± SD14.3 ± 4.714.7 ± 4.313.2 ± 5.3
    Sex, male5029 (52.2)3639 (51.7)1390 (53.5)
    Diabetes duration, yr; mean ± SD7.06 ± 4.257.40 ± 4.356.13 ± 3.80
    Deprivation quintile
     1 (Least deprived)2184 (22.7)1716 (24.4)468 (18.0)
     21985 (20.6)1478 (21.0)507 (19.5)
     31879 (19.5)1369 (19.4)510 (19.6)
     41703 (17.7)1182 (16.8)521 (20.0)
     5 (Most deprived)1776 (18.4)1232 (17.5)544 (20.9)
     Missing114 (1.2)64 (0.9)50 (1.9)
    Any drug claim before OHIP+2988 (31.0)2466 (35.0)522 (20.1)
    • Note: SD = standard deviation.

    • ↵* Unless indicated otherwise.

    • View popup
    Table 2:

    Adjusted segmented regression of hemoglobin A1c before the Ontario Health Insurance Plan (OHIP)+ program began (Jan. 1, 2016, to Dec. 31, 2017) and during OHIP+ (Apr. 1, 2018, to Mar. 31, 2019) to evaluate whether temporal trends changed between time periods (n = 6347 youth; n = 32 802 measurements of hemoglobin A1c)

    Variableβ estimate (95% CI)
    Mean HbA1c on Jan. 1, 2016, by deprivation quintile
     Q1 (least deprived)*8.4718 (8.3752 to 8.5684)
     Q28.6783 (8.5693 to 8.7872)
     Q38.6464 (8.5393 to 8.7535)
     Q48.8280 (8.7020 to 8.9541)
     Q5 (most deprived)8.9478 (8.8191 to 9.0764)
    Slope (change in HbA1c per 90 d) (before OHIP+)0.0037 (−0.0033 to 0.0107)
    Change in slope from before OHIP+ to after Apr. 1, 2018−0.0002 (−0.0004 to 0.0000)
    Age (centred on 14 yr)0.0039 (−0.0078 to 0.0157)
    Male−0.0564 (−0.1427 to 0.0300)
    Duration of diabetes (centred on 7 yr)0.0417 (0.0293 to 0.0541)
    • Note: CI = confidence interval, HbA1c = hemoglobin A1c.

    • ↵* Reference category.

    • View popup
    Table 3:

    Adjusted segmented regression of hemoglobin A1c before the Ontario Health Insurance Plan (OHIP)+ program began (Jan. 1, 2016, to Dec. 31, 2017) and during OHIP+ (Apr. 1, 2018, to Mar. 31, 2019) including interaction terms to evaluate if the change in temporal trend of hemoglobin A1c differed according to socioeconomic status (n = 6347 youth; n = 32 802 measurements of hemoglobin A1c)

    Variableβ estimate (95% CI)
    Mean HbA1c on Jan. 1, 2016, by material deprivation quintile
     Q1 (least deprived)8.5693 (8.4601 to 8.6785)
     Q28.6765 (8.5486 to 8.8043)
     Q38.6002 (8.4708 to 8.7296)
     Q48.8165 (8.6656 to 8.9674)
     Q5 (most deprived)8.8779 (8.7123 to 9.0435)
    Before OHIP+ slope (change in HbA1c per day), by material deprivation quintile
     Q1 (least deprived)−0.0128 (−0.0254 to 0.0002)
     Q20.0011 (−0.0125 to 0.0147)
     Q30.0101 (−0.0062 to 0.0264)
     Q40.0083 (−0.0099 to 0.0264)
     Q5 (most deprived)0.0189 (0.0009 to 0.0387)
    Change in slope from before OHIP+ to after Apr. 1, 2018, by material deprivation quintile
     Q1 (least deprived)0.0001 (−0.0003 to 0.0004)
     Q20.0001 (−0.0003 to 0.0005)
     Q3−0.0002 (−0.0007 to 0.0003)
     Q4−0.0005 (−0.0011 to 0.0001)
     Q5 (most deprived)−0.0007 (−0.0013 to 0.0001)
    Difference in mean HbA1c on Jan. 1, 2016, compared with Q1 (least deprived)
     Q20.1072 (−0.0491 to 0.2635)
     Q30.0309 (−0.1284 to 0.1903)
     Q40.2472 (0.0724 to 0.4221)
     Q5 (most deprived)0.3086 (0.1207 to 0.4965)
    Difference in slope before OHIP+, by material deprivation quintile compared with Q1 (least deprived)
     Q20.0002 (−0.0001 to 0.0004)
     Q30.0003 (0.000 to 0.0005)
     Q40.0002 (0.000 to 0.0005)
     Q5 (most deprived)0.0004 (0.0001 to 0.0006)
    Change in slope from before OHIP+ to after Apr. 1, 2018, by material deprivation quintile compared with Q1 (least deprived)
     Q20.0000 (−0.0005 to 0.0006
     Q3−0.0003 (−0.0009 to 0.0004)
     Q4−0.0006 (−0.0012 to 0.0001)
     Q5 (most deprived)−0.0008 (−0.0015 to 0.0001)
    Age (centred on 14 yr)0.0041 (−0.0077 to 0.0158)
    Male−0.0571 (−0.1435 to 0.0292)
    Duration of diabetes (centred on 7 yr)0.0417 (0.0293 to 0.0541)
    • Note: CI = confidence interval, HbA1c = hemoglobin A1c.

PreviousNext
Back to top

In this issue

CMAJ Open: 10 (2)
Vol. 10, Issue 2
1 Apr 2022
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ Open.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Introduction of publicly funded pharmacare and socioeconomic disparities in glycemic management in children and youth with type 1 diabetes in Ontario, Canada: a population-based trend analysis
(Your Name) has sent you a message from CMAJ Open
(Your Name) thought you would like to see the CMAJ Open web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Introduction of publicly funded pharmacare and socioeconomic disparities in glycemic management in children and youth with type 1 diabetes in Ontario, Canada: a population-based trend analysis
Mohana Giruparajah, Karl Everett, Baiju R. Shah, Peter C. Austin, Shai Fuchs, Rayzel Shulman
Apr 2022, 10 (2) E519-E526; DOI: 10.9778/cmajo.20210214

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Introduction of publicly funded pharmacare and socioeconomic disparities in glycemic management in children and youth with type 1 diabetes in Ontario, Canada: a population-based trend analysis
Mohana Giruparajah, Karl Everett, Baiju R. Shah, Peter C. Austin, Shai Fuchs, Rayzel Shulman
Apr 2022, 10 (2) E519-E526; DOI: 10.9778/cmajo.20210214
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Collections

  • Clinical
    • Pediatrics
      • Adolescents
      • Children
    • Endocrinology & Metabolism
      • Diabetes
  • Nonclinical
    • Health Economics - see also Medicare
    • Health Policy
      • Other health policy
    • Epidemiology
      • Socioeconomic determinants of health

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Preparing manuscripts
  • Manuscript Submission Checklist
  • Publication Fees
  • Forms
  • Editorial Policies
  • Editorial Process
  • Patient-Oriented Research
  • Submit a manuscript
  • Manuscript Progress
  • Submit a response
  • Information for Reviewers

About

  • General Information
  • Staff
  • Editorial Board
  • Contact Us
  • Advertising
  • Media
  • Reprints
  • Copyright and Permissions
  • Accessibility
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 2291-0026

All editorial matter in CMAJ OPEN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].

View CMA's Accessibility policy.

 

Powered by HighWire